Long pentraxin 3: experimental and clinical relevance in cardiovascular diseases
about
Gestational Diabetes Mellitus and Future Cardiovascular Risk: An UpdateNon-invasive imaging of vascular inflammation.Inflammatory biomarkers in atherosclerosis: pentraxin 3 can become a novel marker of plaque vulnerability.Systemic pentraxin-3 levels reflect vascular enhancement and progression in Takayasu arteritis.The long pentraxin PTX3 promotes fibrocyte differentiationMarkers of inflammation associated with plaque progression and instability in patients with carotid atherosclerosisSterile inflammation as a factor in human male infertility: Involvement of Toll like receptor 2, biglycan and peritubular cells.Low circulating pentraxin 3 levels in pregnancy is associated with gestational diabetes and increased apoB/apoA ratio: a 5-year follow-up studyVascular pentraxin 3 controls arterial thrombosis by targeting collagen and fibrinogen induced platelets aggregation.C-reactive protein: clinical and epidemiological perspectives.Pentraxin-3 regulates the inflammatory activity of macrophagesPentraxin 3, ficolin-2 and lectin pathway associated serine protease MASP-3 as early predictors of myocardial infarction - the HUNT2 study.Neutrophil-dependent pentraxin-3 and reactive oxygen species production modulate endothelial dysfunction in haemodialysis patients.C-reactive protein (CRP) but not the related pentraxins serum amyloid P and PTX3 inhibits the proliferation and induces apoptosis of the leukemia cell line Mono Mac 6.Early second-trimester maternal serum markers in prediction of gestational diabetes mellitus.Long-term prognostic significance of pentraxin-3 in patients with acute myocardial infarction: 5-year prospective cohort study.Inflammatory mediators in the diagnosis and treatment of acute pancreatitis: pentraxin-3, procalcitonin and myeloperoxidase.Circulating pentraxin 3 is positively associated with chronic hyperglycemia but negatively associated with plasma aldosterone concentration.
P2860
Q28067405-45DC459F-4F20-49FA-8EB6-5AB407A077CDQ30431621-CD10A860-4E4B-414B-AAA0-7447BCCD9A85Q33768947-8031E4FD-7B83-4DE3-85AA-A758E06CD25AQ34579101-1D4F7585-68B8-4915-B1EC-7B525E591C68Q35182082-B995DB1A-C653-4FB1-8B46-CF8C8A8693A1Q35556624-8F641927-589F-44F6-98C7-E153AB9FE388Q36193766-806C9BC7-EE36-4EBC-8AF7-576D231F38C1Q36538797-9A6B40F3-C751-4BFE-BD35-7A68C13E5CF9Q36869842-ADB15AB1-05A7-4CA4-AFA4-07C3311D92FFQ37599325-0D160ADC-E626-429A-B3B7-2D23E7AC9842Q41683277-D4562E68-9DDB-43B7-B598-4BF8CBCF0AADQ41907221-0C3E0504-9739-49FD-93AF-4F60C5D49670Q46450702-E7BDA56D-5703-4513-8382-370D440D2B7DQ47162111-38AF51A7-8514-45F3-B18C-EDE2AF66173CQ47243601-ABF3B056-F1D6-4121-AF00-D14A2CA1B87FQ51595971-7702741E-7866-4A83-B298-8A3B609FCE14Q55004912-0E00C77D-DEC8-4993-89CC-36A79D01FCCEQ55223194-317824E9-2D5C-45F9-895D-CA2A37A8F301
P2860
Long pentraxin 3: experimental and clinical relevance in cardiovascular diseases
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Long pentraxin 3: experimental and clinical relevance in cardiovascular diseases
@en
type
label
Long pentraxin 3: experimental and clinical relevance in cardiovascular diseases
@en
prefLabel
Long pentraxin 3: experimental and clinical relevance in cardiovascular diseases
@en
P2860
P921
P356
P1476
Long pentraxin 3: experimental and clinical relevance in cardiovascular diseases
@en
P2093
Andrea Baragetti
Fabrizia Bonacina
P2860
P304
P356
10.1155/2013/725102
P577
2013-04-07T00:00:00Z